JKJun Kubota

Jun Kubota

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jun Kubota has a total of 36 co-authors. Here are the top co-authors by number of shared publications:

  • Kazuya Koizumi

    Gastroenterology Medicine Center, Shonan Kamakura General Hospital, 1370-1 Okamoto, Kamakura, Kanagawa, 247-8533, Japan

    6 shared publications
  • Makomo Makazu

    Gastroenterology Medicine Center, Shonan Kamakura General Hospital, 1370-1 Okamoto, Kamakura, Kanagawa, 247-8533, Japan

    6 shared publications
  • Chikamasa Ichita

    Department of Health Data Science, Graduate School of Data Science, Yokohama City University, Yokohama, Japan

    5 shared publications
  • Karen Kimura

    Gastroenterology Medicine Center, Shonan Kamakura General Hospital, 1370-1 Okamoto, Kamakura, Kanagawa, 247-8533, Japan

    5 shared publications
  • Karen Kimura

    Gastroenterology Medicine Center, Shonan Kamakura General Hospital, Kamakura, Japan

    5 shared publications
  • Sakue Masuda

    Department of Gastroenterology Medicine Center, Shonan Kamakura General Hospital, Kamakura, Japan

    5 shared publications

Latest Publications

  • Intracholecystic papillary-tubular neoplasm diagnosed by peroral cholangioscopy

    by Jun Kubota, Kazuya Koizumi, Sakue Masuda, Makomo Makazu, Karen Kimura, Noriko Fujiwara, Toshiyasu Kawahara, Hiroki Yamaue, Harumi Nakamura

  • Long-term survival in a patient with BRCA2-mutated pleomorphic anaplastic pancreatic carcinoma treated with Olaparib maintenance therapy

    by Jun Kubota, Sakue Masuda, Makomo Makazu, Karen Kimura, Shunsuke Imaeda, Shinichi Teshima, Keitaro Wada, Kazuya Koizumi

  • Open Access

    Amyloidosis as an Atypical Cause of Biliary Stricture Diagnosed by Cholangioscopy

    by Jun Kubota, Sakue Masuda, Kazuya Koizumi, Makomo Makazu, Karen Kimura

    Amyloidosis is a rare cause of common bile duct (CBD) stricture that often presents with nonspecific symptoms. We herein report the case of a 61-year-old woman with CBD stricture caused by amyloidosis diagnosed through cholangioscopy and confirmed by a biopsy, with subsequent findings identifying it as AA-type amyloidosis. This condition poses diagnostic challenges owing to its rarity and non-specific manifestations. When common causes are excluded, amyloidosis should be considered in the differential diagnosis of CBD stricture. Advanced imaging and cholangioscopy with targeted biopsies are essential for making an accurate diagnosis. Documenting such cases and further research are vital to improve the understanding and management of amyloidosis-related biliary stricture.

  • Open Access

    Endoscopic Ultrasonography‐guided Variceal Therapy as Salvage Treatment for Rebleeding From Duodenal Varices Following Balloon‐occluded Retrograde Transvenous Obliteration

    by Sakue Masuda, Atsushi Irisawa, Soichiro Nakaya, Jun Kubota, Karen Kimura, Makomo Makazu, Kazuya Koizumi

    Duodenal varices, though rare, are potentially life‐threatening complications of portal hypertension. Management is challenging when balloon‐occluded retrograde transvenous obliteration (BRTO) fails to achieve complete obliteration. Endoscopic ultrasonography‐guided variceal therapy (EUS‐VT) is effective for gastric varices, but reports of duodenal varices remain limited. We present a case of a 71‐year‐old woman with alcoholic liver cirrhosis and duodenal variceal bleeding. Initial hemostasis was achieved with endoscopic variceal ligation, followed by BRTO. However, rebleeding occurred due to incomplete obliteration caused by dual afferent veins. EUS‐VT comprising n‐butyl cyanoacrylate was performed as salvage therapy because of ascites and vascular complexity. Despite technical challenges, EUS‐VT successfully obliterated the varices. Post‐procedural computed tomography showed lipiodol migration into the portal system. No rebleeding or liver dysfunction occurred. Ascites worsened—likely because of BRTO and/or EUS‐VT—but was manageable with low‐dose diuretics. This case highlights EUS‐VT as a feasible option after failed BRTO for duodenal varices. A meticulous technique is essential to preventing glue migration.


  • Open Access

    Secondary Aortoduodenal Fistula Diagnosed after Repeated Gastrointestinal Bleeding Episodes in a Patient With Prior Aortic Graft Surgery

    by Jun Kubota, Chikamasa Ichita, Soichiro Nakaya, Takashi Nishino, Chihiro Sumida, Akiko Sasaki, Daisuke Hama

    Secondary aortoduodenal fistula (sADF) is a rare but life‐threatening complication after aortic graft surgery. Diagnosis is often challenging, particularly when contrast‐enhanced computed tomography (CT) and endoscopy results are inconclusive. We report a case in which diagnosis was challenging due to contrast media allergy and non‐diagnostic endoscopic findings, highlighting the importance of clinical suspicion in such scenarios. A 76‐year‐old man with a history of graft replacement for a ruptured abdominal aortic aneurysm presented with five episodes of gastrointestinal bleeding over 3 months. Despite multiple examinations, no bleeding source was identified. Eventually, after the patient developed hypovolemic shock, contrast‐enhanced CT was performed with informed consent, which revealed contrast extravasation from the aorta into the horizontal portion of the duodenum. Endoscopy subsequently identified an exposed vessel in the same location, confirming the diagnosis of sADF. Endovascular aortic repair was successfully performed. This case underscores the need to consider sADF in patients with aortic grafts who present with recurrent, unexplained gastrointestinal bleeding.


  • Open Access

    Use of a knotted guidewire to manage duodenoscope working channel obstruction

    by Jun Kubota, Sakue Masuda, Kazuya Koizumi, Makomo Makazu, Karen Kimura

  • Open Access

    Difficulty in the diagnosis of pancreatic cancer based on the initial CT report: A retrospective study

    by Kento Shionoya, Kazuya Koizumi, Sakue Masuda, Makomo Makazu, Jun Kubota, Ryuhei Jinushi, Karen Kimura

    The role of computed tomography (CT) in the initial diagnosis of pancreatic cancer (PC) is well-known. CT reports made by radiologists are important as not all patients with PC are examined by specialists; however, some cases are not identified based on CT reports. Diagnosis via imaging of PC is sometimes difficult, and the diagnostic rate of PC and other pancreatic diseases can vary across radiologists. This study aimed to examine the diagnostic rate of PC in initial CT reports and the details of cases with diagnostic difficulties. This single-centered, retrospective study collected clinical data of 198 patients with histologically diagnosed PC between January 2018 and April 2022. Out of these contrast-enhanced CT was performed in 192 cases. PC was not reported as the main diagnosis in 18 patients (9.4%; 11 men and 7 women). Among these 18 cases, intrapancreatic mass lesions were detected in 3 (1.6%), indirect findings such as bile/pancreatic duct stenosis or dilation were detected in 5 (2.6%), and no PC-related findings were found in 10 (5.2%). The specialists suspected PC in 15 of these 18 cases based on initial CT reports. 17 cases were confirmed by endoscopic ultrasound-fine needle aspiration and one by biopsy after upper gastrointestinal endoscopy. To improve accuracy of its diagnosis, it is important that specialists provide feedback to diagnostic radiologists regarding the findings they did not report. Endoscopic ultrasound-fine needle aspiration should be performed by specialists when there is clinical information which indicates pancreatic disease of any kind.


  • Open Access

    Exploration of predictors associated with bleeding in computed tomography-guided core needle splenic biopsy: A retrospective study

    by Sakue Masuda, Toshitaka Tsukiyama, Ryo Rt Daigo, Makomo Makazu, Ryuhei Jinushi, Kazuya Koizumi, Takashi Nishino, Kento Shionoya, Karen Kimura, Chihiro Sumida, et al.

    Splenic diseases may be caused by infections and can be either malignant, such as lymphoma and lung cancer, or benign, such as hemangioma. In some cases, diagnostic uncertainty of imaging persists, and image-guided splenic needle biopsy is a useful diagnostic tool to avoid the disadvantages of incorrect diagnosis, including performing unnecessary splenectomy or not giving the necessary treatment. Splenic biopsies can be divided into ultrasound-guided, computed tomography (CT)-guided fine-needle aspiration, or core needle biopsy (CNB). However, few studies have focused exclusively on complications associated with CT-guided CNB of the spleen. Therefore, we assessed bleeding, the most common complication of CT-guided CNB of the spleen, and evaluated factors associated with the bleeding. Using the biopsy database maintained at the institution, all patients who underwent CT-guided CNB of the spleen between May 2012 and September 2022 were identified retrospectively. The 18 identified patients were divided into post-biopsy bleeding and non-bleeding groups for analysis. In total, 17 patients (94.4%) could be diagnosed accurately with CT-guided CNB. Bleeding complications occurred in 7 cases of CT-guided CNB; of these, 2 patients with Common Terminology Criteria for Adverse Events grade 4 disease required transcatheter arterial embolization. The bleeding group was characterized by diffuse spleen tumors in all cases, with significantly more diffuse spleen tumors than the non-bleeding group. CT-guided CNB is a useful option for neoplastic lesions of the spleen that are difficult to diagnose using imaging alone. However, consideration should be given to post-biopsy bleeding in patients with diffuse splenic tumors.


  • Open Access

    Endoscopic Papillary Balloon Dilation Can Be Safely Performed in Patients on Dual Antiplatelet Therapy: A Pilot Study

    by Sakue Masuda, Ryuhei Jinushi, Kazuya Koizumi, Makomo Makazu, Takashi Nishino, Kento Shionoya, Karen Kimura, Chihiro Sumida, Jun Kubota, Chikamasa Ichita, et al.

    Background and Aims: Endoscopic papillary balloon dilation (EPBD), a low-risk procedure for bleeding, hasbeen suggested as an alternative to endoscopic sphincterotomy for papillary dilatation in patients undergoingendoscopic stone removal who are at a higher risk of bleeding. Several guidelines recommend that combinationof two antiplatelet agents should be reduced to single antiplatelet therapy when endoscopic sphincterotomyis performed. However, there is no evidence that EPBD affects the risk of bleeding in patients receiving acombination of two antiplatelet agents; thus, we aimed to explore this problem. Methods: We included 31 patients who underwent EPBD for common bile duct stones at our hospital fromMay 2014 to August 2022 and received either a combination of two antiplatelet agents or single antiplatelettherapy prior to the procedure. The group receiving a combination of two antiplatelet agents included patientswho underwent EPBT without antiplatelet therapy withdrawal or with a shorter withdrawal period than thoserecommended by the guidelines. Results: In the group that received a combination of two antiplatelet agents, one of the two antiplateletagents used was thienopyridine. No bleeding was observed after EPBD in this study. We did not findany significant between-group differences in hemoglobin levels and rate of post-endoscopic retrogradecholangiopancreatography pancreatitis. Conclusions: In patients treated with a combination of two antiplatelet agents, EPBD could be safely performedwithout bleeding. Therefore, future prospective studies are warranted.


  • Open Access

    Severe Generalized Epidemic Myalgia in an Adult due to Human Parechovirus Type 3: A Case Report

    by Sakue Masuda, Kazuya Koizumi, Morihiko Sato, Haruki Uojima, Karen Kimura, Takashi Nishino, Chikamasa Ichita, Akiko Sasaki, Makomo Makazu, Masahiro Kobayashi, et al.

    Parechovirus A type 3 (PeVA3) is most commonly transmitted to adults from children. Although PeVA3 infection is rarely diagnosed, as the symptoms are generally mild and self-limiting, this infection has been associated with epidemic myalgia in Japan. The patient, a 37-year-old man, presented with severe generalized myalgia, inability to open his mouth, and orchitis, which resolved over a period of 10 days. All members of his family were thought to have been infected with PeVA3 during a visit to an amusement park. Although the source of infection and inability to open his mouth are atypical, the acute generalized muscle symptoms made us suspect epidemic myalgia and enabled us to make a diagnosis of PeVA3 infection.